Annual EBITDA:
-$286.21M+$135.55M(+32.14%)Summary
- As of today, LEGN annual EBITDA is -$286.21 million, with the most recent change of +$135.55 million (+32.14%) on December 31, 2024.
- During the last 3 years, LEGN annual EBITDA has risen by +$93.87 million (+24.70%).
- LEGN annual EBITDA is now -2144.66% below its all-time high of $14.00 million, reached on December 1, 2017.
Performance
LEGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$37.39M-$21.31M(-132.50%)Summary
- As of today, LEGN quarterly EBITDA is -$37.39 million, with the most recent change of -$21.31 million (-132.50%) on September 30, 2025.
- Over the past year, LEGN quarterly EBITDA has increased by +$27.49 million (+42.37%).
- LEGN quarterly EBITDA is now -216.58% below its all-time high of -$11.81 million, reached on March 31, 2019.
Performance
LEGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$171.25M+$27.49M(+13.83%)Summary
- As of today, LEGN TTM EBITDA is -$171.25 million, with the most recent change of +$27.49 million (+13.83%) on September 30, 2025.
- Over the past year, LEGN TTM EBITDA has increased by +$158.08 million (+48.00%).
- LEGN TTM EBITDA is now -1349.80% below its all-time high of -$11.81 million, reached on March 31, 2019.
Performance
LEGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LEGN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +32.1% | +42.4% | +48.0% |
| 3Y3 Years | +24.7% | - | - |
| 5Y5 Years | -117.2% | - | - |
LEGN EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +34.9% | -132.5% | +69.7% | -38.8% | +51.3% |
| 5Y | 5-Year | -117.2% | +34.9% | -132.5% | +69.7% | -99.4% | +51.3% |
| All-Time | All-Time | -2144.7% | +34.9% | -216.6% | +69.7% | -1349.8% | +51.3% |
LEGN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$37.39M(-132.5%) | -$171.25M(+13.8%) |
| Jun 2025 | - | -$16.08M(+64.6%) | -$198.74M(+9.4%) |
| Mar 2025 | - | -$45.45M(+37.2%) | -$219.26M(+23.3%) |
| Dec 2024 | -$286.21M(+32.1%) | -$72.33M(-11.5%) | -$285.95M(+13.2%) |
| Sep 2024 | - | -$64.88M(-77.3%) | -$329.33M(+6.4%) |
| Jun 2024 | - | -$36.60M(+67.4%) | -$351.80M(-11.6%) |
| Mar 2024 | - | -$112.14M(+3.1%) | -$315.20M(-55.2%) |
| Dec 2023 | -$421.76M(+4.1%) | -$115.70M(-32.5%) | -$203.05M(+3.6%) |
| Sep 2023 | - | -$87.35M(+29.2%) | -$210.69M(-70.8%) |
| Dec 2022 | -$439.66M(-15.7%) | -$123.34M(-8.4%) | -$123.34M(+56.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$380.08M(-72.5%) | -$113.75M(-36.6%) | -$282.92M(-67.2%) |
| Sep 2021 | - | -$83.27M(+3.1%) | -$169.17M(-96.9%) |
| Jun 2021 | - | -$85.90M(-93.4%) | -$85.90M(+47.0%) |
| Dec 2020 | -$220.32M(-67.2%) | - | - |
| Mar 2020 | - | -$44.41M(+27.9%) | -$162.17M(-25.2%) |
| Dec 2019 | -$131.79M(-858.5%) | -$61.60M(-122.3%) | -$129.57M(-90.6%) |
| Sep 2019 | - | -$27.71M(+2.6%) | -$67.97M(-68.8%) |
| Jun 2019 | - | -$28.45M(-140.8%) | -$40.26M(-240.8%) |
| Mar 2019 | - | -$11.81M | -$11.81M |
| Dec 2018 | -$13.75M(-198.2%) | - | - |
| Dec 2017 | $14.00M | - | - |
FAQ
- What is Legend Biotech Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Legend Biotech Corporation?
- What is Legend Biotech Corporation annual EBITDA year-on-year change?
- What is Legend Biotech Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Legend Biotech Corporation?
- What is Legend Biotech Corporation quarterly EBITDA year-on-year change?
- What is Legend Biotech Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Legend Biotech Corporation?
- What is Legend Biotech Corporation TTM EBITDA year-on-year change?
What is Legend Biotech Corporation annual EBITDA?
The current annual EBITDA of LEGN is -$286.21M
What is the all-time high annual EBITDA for Legend Biotech Corporation?
Legend Biotech Corporation all-time high annual EBITDA is $14.00M
What is Legend Biotech Corporation annual EBITDA year-on-year change?
Over the past year, LEGN annual EBITDA has changed by +$135.55M (+32.14%)
What is Legend Biotech Corporation quarterly EBITDA?
The current quarterly EBITDA of LEGN is -$37.39M
What is the all-time high quarterly EBITDA for Legend Biotech Corporation?
Legend Biotech Corporation all-time high quarterly EBITDA is -$11.81M
What is Legend Biotech Corporation quarterly EBITDA year-on-year change?
Over the past year, LEGN quarterly EBITDA has changed by +$27.49M (+42.37%)
What is Legend Biotech Corporation TTM EBITDA?
The current TTM EBITDA of LEGN is -$171.25M
What is the all-time high TTM EBITDA for Legend Biotech Corporation?
Legend Biotech Corporation all-time high TTM EBITDA is -$11.81M
What is Legend Biotech Corporation TTM EBITDA year-on-year change?
Over the past year, LEGN TTM EBITDA has changed by +$158.08M (+48.00%)